Bone Strength

Bone Strength - most related articles:

- Obesity may be bad for bone health - 6.3
- Merck's Odanacatib increases bone mineral density - 4.5
- Fat mass helps build bone mass in girls - 4.2
- Osteoporosis drugs linked to atypical fractures - 4.2
- Prolia - new injectable osteoporosis treatment for postmenopausal women - 4.1
- Bone density related to bone erosion in rheumatoid arthritis patients - 4
- Osteoporosis drugs increase bone necrosis risk - 4
- Reduced muscle strength increases Alzheimer's disease risk - 4
- Strong thigh muscles protect women from osteoarthritis symptoms - 4
- Bone density unnecessary in women taking osteoporosis drugs - 3.9

Bone Strength articles

Fat mass helps build bone mass in girls
According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), fat mass is important in increasing bone size and thickness, but this effect appears to be stronger in girls than boys.

Osteoporosis drug may improve immune system
An osteoporosis drug zoledronic acid (Reclast) proven to save lives after hip fractures may do so by strengthening the body's immune system, revealed by geriatrics researchers at Duke University Medical Center.

Bone density unnecessary in women taking osteoporosis drugs
Monitoring bone mineral density in postmenopausal women taking osteoporosis drugs (bisphosphonates) is unnecessary and potentially misleading, revealed by researchers through a new study published on bmj.com.

Osteoporotic fracture risky in older adults
Women and men age 60 years or older who have a low-trauma osteoporotic fracture have an increased risk of death for the following 5 to 10 years, compared to the general population, and those who experience another fracture increase their risk of death further for an additional 5 years, according to a study in the February 4 issue of JAMA.

Merck's Odanacatib increases bone mineral density
2 year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose-dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased indices of bone resorption compared to placebo in postmenopausal women with low BMD.

Breast cancer spread stopped by bone drug
Researchers at Washington University School of Medicine in St. Louis found that women treated for stage II/III breast cancer who also received a bone strengthening drug zoledronic acid were less likely to have breast tumor cells growing in their bones after three months.

6 Bone Strength articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
5.51